title: Dosage of rituximab in systemic sclerosis: 2-year results of five cases.
authors.affiliation: Division of Rheumatology and Immunology, Medical University Graz Auenbruggerplatz, 15, 8036, Graz, Austria. florentine.fuerst@medunigraz.at.
authors.forename: F C
authors.initials: FC
authors.lastname: Moazedi-Fuerst
authors.forename: S M
authors.initials: SM
authors.lastname: Kielhauser
authors.forename: K
authors.initials: K
authors.lastname: Bodo
authors.forename: W B
authors.initials: WB
authors.lastname: Graninger
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D000069283:Rituximab; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab